|
Volumn 20, Issue 15, 2010, Pages 4550-4554
|
Discovery of novel sphingosine kinase-1 inhibitors. Part 2
|
Author keywords
3 Hydroxypyrrolidine 2 carboxamides; ADME; Enzyme; Heterocycles; Inhibitors; Oxadiazole; PK; SK1; Solubility; Sphingosine kinase
|
Indexed keywords
PHOSPHOTRANSFERASE INHIBITOR;
SPHINGOSINE KINASE 1;
SPHINGOSINE KINASE 1 INHIBITOR;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
AREA UNDER THE CURVE;
ARTICLE;
DRUG BIOAVAILABILITY;
DRUG HALF LIFE;
DRUG SOLUBILITY;
ENZYME INHIBITION;
HUMAN;
HUMAN CELL;
IC 50;
IN VITRO STUDY;
LIPOPHILICITY;
MAXIMUM PLASMA CONCENTRATION;
MICROSOME;
NONHUMAN;
RAT;
TIME TO MAXIMUM PLASMA CONCENTRATION;
ANIMALS;
BENZALDEHYDES;
DRUG EVALUATION, PRECLINICAL;
ENZYME INHIBITORS;
HUMANS;
LITHIUM;
MICROSOMES, LIVER;
PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR);
RATS;
RATTUS;
|
EID: 77955412772
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2010.06.019 Document Type: Article |
Times cited : (43)
|
References (18)
|